Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: Expression studies in biopsies of type 2 diabetic patients

Renal Failure

Volumn 23, Issue 3-4, 2001, Pages 483-493

  Bortoloso, Elena ^a   Prete, Dorella Del ^a   Gambaro, Giovanni ^a   Vestra, Michele Dalla ^a   Saller, Alois ^a   Baggio, Bruno ^a   Antonucci, Francesco ^b   Fioretto, Paola ^a   Anglani, Franca ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b General Hospital   (Italy)

^c Divisione di Cardiologia   (Italy)

Author keywords

Renal biopsy; Type 2 diabetes mellitus; VEGF; VEGF receptors

Indexed keywords

ISOPROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DOWN REGULATION; GLOMERULUS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY INTERSTITIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; DENSITOMETRY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034916485     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100104731     Document Type: Conference Paper

References (26)

1. Vascular endothelial growth factor and diabetes. The agonist versus antagonist paradox
2. The biology of vascular endothelial growth factor
3. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
4. High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
5. Different signal transduction properties of KDR and Flt-1: Two receptors for vascular endothelial growth factor
6. The vascular endothelial growth factor receptor Flt-1 mediates biological activities
7. Vascular permeability factor mRNA and protein expression in human kidney
8. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney
9. Vascular endothelial growth factor expression is increased in renal cell carcinoma
10. 125I) VEGF binding sites
11. A potential role for angiotensin II induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
12. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy
13. Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy
14. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM
15. Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients
16. Patterns of renal injury in NIDDM patients with microalbuminuria
17. A comparative kinetic RT/PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens
18. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
19. Vascular endothelial growth factor and its receptors in normal human testicular tissue
20. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
21. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases
22. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation
23. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
24. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
25. VEGF regulates endothelial cell survival by the PI3-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
26. Matrix accumulation in diabetes: An imbalance between pro- and antiangiogenic factors?